1. European task force on atopic dermatitis position paper
- Author
-
Regina Fölster-Holst, Thomas Werfel, Michael J. Cork, Alain Taieb, Julien Seneschal, Carle Paul, Åke Svensson, Carsten Flohr, Thomas Bieber, Phyllis I. Spuls, Sébastien Barbarot, Uwe Gieler, J. Ring, Christian Vestergaard, L.B. von Kobyletzki, Stéphanie Christen-Zaech, Jacob P. Thyssen, M S de Bruin-Weller, DirkJan Hijnen, Ulf Darsow, Andreas Wollenberg, J. F. Stalder, Magdalena Trzeciak, Carlo Gelmetti, Pavel V Chernyshov, Dagmar Simon, M. Deleuran, B. Kunz, L. De Raeve, Surgical clinical sciences, Dermatology, Skin function and permeability, APH - Methodology, APH - Quality of Care, Aarhus University Hospital, Ludwig Maximilians University of Munich, Hôpital Municipal de Munich, Partenaires INRAE, Centre hospitalier universitaire de Nantes (CHU Nantes), Lausanne University Hospital, University of Amsterdam [Amsterdam] (UvA), King‘s College London, Medical University of Gdańsk, Lund University [Lund], Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Larrey [Toulouse], CHU Toulouse [Toulouse], University of Bonn, Hannover Medical School [Hannover] (MHH), Department of Dermatology, Venerology and Allergology, Universitätsklinikum Würzburg, Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), Justus-Liebig-Universität Gießen (JLU), University of Sheffield, Vrije Universiteit Brussel (VUB), Dermatologikum Hamburg, Universität Bern- University of Bern [Bern], National Medical University Kief, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Università degli Studi di Milano [Milano] (UNIMI), Christine Kühne Center, University Medical Center [Utrecht], University of Copenhagen = Københavns Universitet (KU), ProdInra, Migration, Ludwig-Maximilians University [Munich] (LMU), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Justus-Liebig-Universität Gießen = Justus Liebig University (JLU), Università degli Studi di Milano = University of Milan (UNIMI), and University of Copenhagen = Københavns Universitet (UCPH)
- Subjects
0301 basic medicine ,Male ,Pediatrics ,Azathioprine ,disease flares ,Ultraviolet therapy ,Preconception Care ,030207 dermatology & venereal diseases ,0302 clinical medicine ,tacrolimus ointment ,Dermatitis, Atopic/therapy ,guidelines ,Dermatologic Agents/therapeutic use ,Atopic dermatitis ,calcineurin inhibitors ,3. Good health ,Europe ,Infectious Diseases ,Female ,Ultraviolet Therapy ,eczema ,pregnancy ,treatment options ,medicine.drug ,Adult ,medicine.medical_specialty ,Advisory Committees ,Dermatology ,Dermatitis, Atopic ,03 medical and health sciences ,[SDV.MHEP.PED] Life Sciences [q-bio]/Human health and pathology/Pediatrics ,children ,medicine ,Humans ,Lactation ,Pregnancy ,[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics ,business.industry ,Chlorhexidine ,birth outcomes ,[SDV.MHEP.DERM] Life Sciences [q-bio]/Human health and pathology/Dermatology ,medicine.disease ,Tacrolimus ,[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition ,030104 developmental biology ,antirheumatic drugs ,maternal stress ,Position paper ,Dermatologic Agents ,business ,[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition ,[SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology - Abstract
International audience; Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the treatment of pregnant or lactating women and for adults planning to have a child are often lacking. This position paper from the European Task force on Atopic Dermatitis (ETFAD) is based on up-to-date scientific literature on treating pregnant and lactating women as wells as adults with AD planning to have a child. It is based on the expert opinions of members of the ETFAD and on existing safety data on the proposed treatments, many of which are derived from patients with other inflammatory diseases or from transplantation medicine. For treating future parents, as well as pregnant and lactating women with AD, the use of topical treatments including moisturizers, topical corticosteroids, tacrolimus, antiseptics such as chlorhexidine, octenidine, potassium permanganate and sodium hypochlorite (bleach) is deemed to be safe. Ultraviolet (UV) therapy may also be used. Systemic treatment should be prescribed only after careful consideration. According to the opinion of the ETFAD, treatment should be restricted to systemic corticosteroids and cyclosporine A, and, in selected cases, azathioprine.
- Published
- 2019
- Full Text
- View/download PDF